Back to Upstate or All Bud/Flower

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This page was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Dosing Look-Up Table (Estimated)

0.01/g2/mg THCTrace CBD
0.05/g10/mg THCTrace CBD
0.1/g20/mg THCTrace CBD
0.15/g30/mg THCTrace CBD
0.2/g40/mg THCTrace CBD
0.25/g50/mg THCTrace CBD
0.3/g60/mg THCTrace CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
Australia Upstate
Designation
Polaris T20
Cultivar/Strain
Mimosa Orange Punch
Classification
Hybrid
Chemotype
Type I: High THC
Flower Provided
Trimmed Whole Flower
THC Potential Range (±10%)
18-22%
CBD Potential Range (±10%)
<1%
Cultivated/Produced by
Australia Little Green Pharma
Cultivated in
Flag of Denmark Denmark
Irradiation
Beta-Irradiated
Monograph Conformity
5.1.4
Imported by
Scotland Hilltop Leaf
Imported as
Schedule II: Finished Product
Packaged in
Flag of Denmark Denmark

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Montu/IPS (1.2KG)

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Main Partner Pharmacy

Pharmacy Distributor

Dispensing Patient Pharmacies

Product Description Video Reviews3 Patient Reviews

About Mimosa Orange Punch

Ingeniously created by a further careful back crossing of our famous Orange Punch with the 2020 sensation Mimosa Evo.

Barney's Farm Logo

Bred by Dutch Flag Barney's Farm

The Mimosa evolution continues with this new explosive orange flavoured super compact sensation, behold another brand-new super strain from the lab at Barney’s Farm. Ingeniously created by a further careful back crossing of our famous Orange Punch with the 2020 sensation Mimosa Evo.

This additional genetic infusion resulted in an astounding fast producer of gorgeous smelling bud; beta-caryophyllene, linalool and limonene terpenes create a sensational citrus-like, tangerine-candy sweet aroma. This crossing produced an extra compact plant compared to Mimosa Evo yet manages to maintain the staggering high production performance.

Without a doubt one of the most colourful editions to our Cali Collection, the accompanied photos are from the BF Lab final harvest assessment and feature this elegant plant’s deep gradients of purple, such beauty is rarely seen anywhere in the plant world, a real aesthetic treat for even the most experienced grower. This champion will be an utter delight, a very sturdy plant producing multiple large dense highly resinous and heavy buds, covered in bright orange pistils just dripping in trichomes. During testing it’s been described as an indoor cultivator’s dream! A rapid flowering period of just 55 to 60 days harvesting 700g/m2.

Outdoors in ideal conditions Mimosa x Orange Punch Strain reaches heights of 1.5m – 1.8 metres producing in excess of 1.5kg of huge very compact colas of exquisite and delicious cannabis. At harvest time the enjoyment of this strain really goes up a notch, dense heavy buds are extremely easy to manicure and with the onset of the ever-increasing delicious citrusy candy orange aromas come to life. THC has been tested at an incredible 30%.

Description provided by Barney's Farm.

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

Australia About Cannim Australia Pty Ltd

Upstate Logo

We are a leading global cannabis company providing GACP and GMP certified medical solutions to deliver better physical and mental health outcomes for patients around the world.

Pioneering better health outcomes for those in need by harnessing the power of therapeutic cannabis.

Based in Sydney, Australia, Cannim was established in 2017 to bring the benefits of medicinal cannabis to the world.

Back in 2017, Cannabis was still stigmatised and cultivation considered an art form. Built on the 3 core pillars of Safety, Science, and Scale, Cannim established an organisation that could show people that Cannabis was a real medicine, consistently develop it to pharmaceutical standards, and establish networks to reach a wide audience of needy people.

Just 4 years later, Cannim cultivates in Jamaica and Australia, and established a network of EU GMP manufacturers as well as formed alliances in education and healthcare, offering products & services to bring relief in many forms to people across the world.

This industry is nascent and this is only the beginning of the journey to establish Cannabis as a reputable medicine around the world. Cannim continues to create scale in its operations, giving us the ability to meet the needs of the ever-growing body of medicinal cannabis users. Cannim is pioneering the development of the category, creating new ways of administration for patients, leading research and education into the effects of cannabis on a variety of conditions, pioneering its usefulness for others, and ensuring those in need get what they need when they need it at a price that's fair.

cannim.com

  Information provided is partially -sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)